{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T16:41:13Z","timestamp":1762101673782},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,6,1]],"date-time":"2015-06-01T00:00:00Z","timestamp":1433116800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Hong Kong Health and Medical Research Fund","award":["11101052"],"award-info":[{"award-number":["11101052"]}]},{"name":"General Research Fund","award":["785112"],"award-info":[{"award-number":["785112"]}]},{"name":"China 12th 5-year Mega project for HIV\/AIDS","award":["2012ZX10001006"],"award-info":[{"award-number":["2012ZX10001006"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.1016\/j.antiviral.2015.02.006","type":"journal-article","created":{"date-parts":[[2015,3,11]],"date-time":"2015-03-11T22:17:06Z","timestamp":1426112226000},"page":"1-9","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Reconstitution and characterization of antibody repertoires of HIV-1-infected \u201celite neutralizers\u201d"],"prefix":"10.1016","volume":"118","author":[{"given":"Zehua","family":"Sun","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingjing","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xintao","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yiming","family":"Shao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mei-Yun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.antiviral.2015.02.006_b0005","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.immuni.2014.04.008","article-title":"Structural delineation of a quaternary, cleavage-dependent epitope at the gp41-gp120 interface on intact HIV-1 Env trimers","volume":"40","author":"Blattner","year":"2014","journal-title":"Immunity"},{"key":"10.1016\/j.antiviral.2015.02.006_b0010","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1126\/science.7973652","article-title":"Efficient neutralization of primary isolates of HIV-1 by a recombinant human monoclonal antibody","volume":"266","author":"Burton","year":"1994","journal-title":"Science"},{"key":"10.1016\/j.antiviral.2015.02.006_b0015","doi-asserted-by":"crossref","first-page":"e8805","DOI":"10.1371\/journal.pone.0008805","article-title":"Analysis of memory B cell responses and isolation of novel monoclonal antibodies with neutralizing breadth from HIV-1-infected individuals","volume":"5","author":"Corti","year":"2010","journal-title":"PLoS ONE"},{"key":"10.1016\/j.antiviral.2015.02.006_b0020","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.immuni.2014.04.009","article-title":"Broadly neutralizing HIV antibodies define a glycan-dependent epitope on the prefusion conformation of gp41 on cleaved envelope trimers","volume":"40","author":"Falkowska","year":"2014","journal-title":"Immunity"},{"key":"10.1016\/j.antiviral.2015.02.006_b0025","doi-asserted-by":"crossref","first-page":"3718","DOI":"10.4049\/jimmunol.0803115","article-title":"Contribution of nonneutralizing vaccine-elicited antibody activities to improved protective efficacy in rhesus macaques immunized with Tat\/Env compared with multigenic vaccines","volume":"182","author":"Florese","year":"2009","journal-title":"J. Immunol."},{"key":"10.1016\/j.antiviral.2015.02.006_b0030","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/nature06106","article-title":"Fc receptor but not complement binding is important in antibody protection against HIV","volume":"449","author":"Hessell","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.antiviral.2015.02.006_b0035","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.1099\/vir.0.043802-0","article-title":"Profiles of neutralizing antibody response in chronically human immunodeficiency virus type 1 clade B\u2032-infected former plasma donors from China naive to antiretroviral therapy","volume":"93","author":"Hu","year":"2012","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.antiviral.2015.02.006_b0040","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1038\/nature11544","article-title":"Broad and potent neutralization of HIV-1 by a gp41-specific human antibody","volume":"491","author":"Huang","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.antiviral.2015.02.006_b0045","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1038\/nm1624","article-title":"Broad HIV-1 neutralization mediated by CD4-binding site antibodies","volume":"13","author":"Li","year":"2007","journal-title":"Nat. Med."},{"key":"10.1016\/j.antiviral.2015.02.006_b0050","doi-asserted-by":"crossref","first-page":"4033","DOI":"10.1128\/JVI.02588-06","article-title":"An affinity-enhanced neutralizing antibody against the membrane-proximal external region of human immunodeficiency virus type 1 gp41 recognizes an epitope between those of 2F5 and 4E10","volume":"81","author":"Nelson","year":"2007","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2015.02.006_b0055","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1089\/aid.1994.10.1651","article-title":"A broadly neutralizing human monoclonal antibody against gp41 of human immunodeficiency virus type 1","volume":"10","author":"Purtscher","year":"1994","journal-title":"AIDS Res. Hum. Retroviruses"},{"key":"10.1016\/j.antiviral.2015.02.006_b0060","doi-asserted-by":"crossref","first-page":"7306","DOI":"10.1128\/JVI.76.14.7306-7321.2002","article-title":"The broadly neutralizing anti-human immunodeficiency virus type 1 antibody 2G12 recognizes a cluster of alpha1\u21922 mannose residues on the outer face of gp120","volume":"76","author":"Scanlan","year":"2002","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2015.02.006_b0065","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.celrep.2014.04.001","article-title":"Antibody 8ANC195 reveals a site of broad vulnerability on the HIV-1 envelope spike","volume":"7","author":"Scharf","year":"2014","journal-title":"Cell Rep."},{"key":"10.1016\/j.antiviral.2015.02.006_b0070","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1038\/nature07930","article-title":"Broad diversity of neutralizing antibodies isolated from memory B cells in HIV-infected individuals","volume":"458","author":"Scheid","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.antiviral.2015.02.006_b0075","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1126\/science.1207227","article-title":"Sequence and structural convergence of broad and potent HIV antibodies that mimic CD4 binding","volume":"333","author":"Scheid","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.antiviral.2015.02.006_b0080","doi-asserted-by":"crossref","first-page":"5831","DOI":"10.1128\/JVI.00273-13","article-title":"Identification of dominant antibody-dependent cell-mediated cytotoxicity epitopes on the hemagglutinin antigen of pandemic H1N1 influenza virus","volume":"87","author":"Srivastava","year":"2013","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2015.02.006_b0085","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1089\/08892220152741450","article-title":"A potent cross-clade neutralizing human monoclonal antibody against a novel epitope on gp41 of human immunodeficiency virus type 1","volume":"17","author":"Stiegler","year":"2001","journal-title":"AIDS Res. Hum. Retroviruses"},{"key":"10.1016\/j.antiviral.2015.02.006_b0090","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1126\/science.1178746","article-title":"Broad and potent neutralizing antibodies from an African donor reveal a new HIV-1 vaccine target","volume":"326","author":"Walker","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.antiviral.2015.02.006_b0095","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1038\/nature10373","article-title":"Broad neutralization coverage of HIV by multiple highly potent antibodies","volume":"477","author":"Walker","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.antiviral.2015.02.006_b0100","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.cell.2014.01.052","article-title":"Structural insights on the role of antibodies in HIV-1 vaccine and therapy","volume":"156","author":"West","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.antiviral.2015.02.006_b0105","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1126\/science.1187659","article-title":"Rational design of envelope identifies broadly neutralizing human monoclonal antibodies to HIV-1","volume":"329","author":"Wu","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.antiviral.2015.02.006_b0110","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1126\/science.1207532","article-title":"Focused evolution of HIV-1 neutralizing antibodies revealed by structures and deep sequencing","volume":"333","author":"Wu","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.antiviral.2015.02.006_b0115","doi-asserted-by":"crossref","DOI":"10.4161\/mabs.3.4.15740","article-title":"A single mutation turns a non-binding germline-like predecessor of broadly neutralizing antibody into a binding antibody to HIV-1 envelope glycoproteins","volume":"3","author":"Yuan","year":"2011","journal-title":"MAbs"},{"key":"10.1016\/j.antiviral.2015.02.006_b0120","doi-asserted-by":"crossref","first-page":"6903","DOI":"10.1016\/j.vaccine.2011.07.046","article-title":"Putative rhesus macaque germline predecessors of human broadly HIV-neutralizing antibodies: differences from the human counterparts and implications for HIV-1 vaccine development","volume":"29","author":"Yuan","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.antiviral.2015.02.006_b0125","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1586\/erv.10.49","article-title":"New flow cytometric assays for monitoring cell-mediated cytotoxicity","volume":"9","author":"Zaritskaya","year":"2010","journal-title":"Expert Rev. Vaccines"},{"key":"10.1016\/j.antiviral.2015.02.006_b0130","doi-asserted-by":"crossref","first-page":"9233","DOI":"10.1128\/JVI.78.17.9233-9242.2004","article-title":"Identification and characterization of a new cross-reactive human immunodeficiency virus type 1-neutralizing human monoclonal antibody","volume":"78","author":"Zhang","year":"2004","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2015.02.006_b0135","doi-asserted-by":"crossref","first-page":"e44241","DOI":"10.1371\/journal.pone.0044241","article-title":"Identification and characterization of a broadly cross-reactive HIV-1 human monoclonal antibody that binds to both gp120 and gp41","volume":"7","author":"Zhang","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.antiviral.2015.02.006_b0140","doi-asserted-by":"crossref","first-page":"11401","DOI":"10.1128\/JVI.05312-11","article-title":"Cross-reactive HIV-1-neutralizing human monoclonal antibodies identified from a patient with 2F5-like antibodies","volume":"85","author":"Zhu","year":"2011","journal-title":"J. Virol."}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354215000340?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354215000340?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,24]],"date-time":"2018-09-24T09:54:32Z","timestamp":1537782872000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354215000340"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6]]},"references-count":28,"alternative-id":["S0166354215000340"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2015.02.006","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2015,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Reconstitution and characterization of antibody repertoires of HIV-1-infected \u201celite neutralizers\u201d","name":"articletitle","label":"Article Title"},{"value":"Antiviral Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.antiviral.2015.02.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}